Archive

Young adult mental health claims have risen 80% in a decade, Discovery Health data shows, as earlier care-seeking reshapes demand.

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

Discovery’s headline earnings are expected to rise by up to 36%, supported by South African and Vitality growth.

GEMS principal officer Stan Moloabi is suspended during an internal review. Learn more about this significant development.

Gauteng healthcare bribery allegations involve queue jumping, patient files and medicine collection. Officials face investigation.

GLP-1 generics could cut obesity drug costs, challenge illegal sales and expand access as more semaglutide products seek approval.

Research funding has partially recovered with the reopening of NIH grants, but new restrictions underscore the need for domestic investment.

Cancer sugar shield research from UCT reveals how tumours evade immunity and could support new vaccines, biomarkers and precision therapies.